138 related articles for article (PubMed ID: 29561526)
1. Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
Wu D; Hu Y; Wei Q; Tian C; Bian Y
Clin Nucl Med; 2018 Jun; 43(6):428-430. PubMed ID: 29561526
[TBL] [Abstract][Full Text] [Related]
2. An unusual case of synchronous renal cell carcinoma in a horseshoe kidney and intrahepatic cholangiocarcinoma.
Anthony MP; Mak H; Khong PL
Clin Nucl Med; 2009 Dec; 34(12):922-3. PubMed ID: 20139836
[No Abstract] [Full Text] [Related]
3. Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
Xia X; Hu F; Qin C; Liu F; Lan X
Clin Nucl Med; 2019 Jan; 44(1):38-39. PubMed ID: 30371589
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
5. Situs Inversus Totalis and Cholangiocarcinoma of the Gallbladder Detected by 18F-FDG PET/CT.
Calabria FF; Leporace M; Bagnato A
Clin Nucl Med; 2018 Jun; 43(6):439-440. PubMed ID: 29538026
[TBL] [Abstract][Full Text] [Related]
6. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Takahashi Y; Sato S; Ishitobi H; Nagaoka M; Kobayashi Y; Fukuhara H; Yuki M; Komazawa Y; Kuroda H; Shizuku T
Intern Med; 2017 Nov; 56(22):3027-3031. PubMed ID: 28943569
[TBL] [Abstract][Full Text] [Related]
8. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Ge J; Zuo C; Guan Y; Liang Z
Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
[No Abstract] [Full Text] [Related]
10. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
[TBL] [Abstract][Full Text] [Related]
12. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
[TBL] [Abstract][Full Text] [Related]
14. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
[TBL] [Abstract][Full Text] [Related]
17. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Sasikumar A; Joy A; Nanabala R; Unni M; Tk P
Clin Nucl Med; 2016 Dec; 41(12):e517-e519. PubMed ID: 27749421
[TBL] [Abstract][Full Text] [Related]
18. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
[TBL] [Abstract][Full Text] [Related]
19. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
Moon CM; Bang S; Chung JB
Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967
[TBL] [Abstract][Full Text] [Related]
20. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]